Skip to main content
Caplight Logo









Eolo Pharma

Eolo Pharma

Private
MontevideoHealthcare & Life Scienceshttps://eolo-pharma.com/

Last Round

Series A

Extension

Jul 15, 2022

Total Funding Raised

$8.4M

Company Overview

Eolo Pharma is a clinical-stage biotechnology company developing novel small-molecule therapies for the treatment of obesity and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule drugsobesity treatmentmetabolic diseasebiotechbrown adipose tissueclinical-stage biotechenergy expenditurepreclinical developmentGLP-1 alternativetherapeuticsdrug developmentbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eolo Pharma Comparables

Compare Eolo Pharma with similar companies based on industry and business-model similarity.

Eolo Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Equator Therapeutics
86%
Cantoni Therapeutics
84%
Incipiam Pharma
81%

Eolo Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 15, 2022
Series ADec 31, 2019
Series ADec 1, 2019
SeedDec 1, 2016

Key People

Founding team and executive leadership

Carlos Batthyány

Founder CMO Eolo Pharma

Founding Team

María Pía Garat

Chief Executive Officer

Executive Team

Eolo Pharma Investors

Notable investors and investment history

Eolo Pharma investors
InvestorRounds
CITESSeries A, Series A Extension, Seed
Ficus CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 432% MoM, reaching 2.1K.

Eolo Pharma Filings

Explore SEC and related filing metadata, where available.

Eolo Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eolo Pharma's valuation, stock price, and market status.

Is Eolo Pharma a public or private company?

Eolo Pharma is a private company.

What is the current stock price of Eolo Pharma?

Eolo Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Eolo Pharma worth (valuation)?

Valuation information for Eolo Pharma is not publicly available.

Can I buy Eolo Pharma stock?

Eolo Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eolo Pharma's last funding round?

Eolo Pharma's most recent funding round was Series A on December 31, 2019.

Who are the main investors in Eolo Pharma?

Key investors in Eolo Pharma include Ficus Capital.

Will Eolo Pharma IPO soon?

No public IPO plans have been announced for Eolo Pharma.

How can I track Eolo Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eolo Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontevideo
Employee Range13
Year Founded2017
Last FundingJul 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?